Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Predicting Adverse Outcomes Using Machine Learning of COPD Patients in Hong Kong

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

This study aims to develop predictive models for patients with a diagnosis of COPD at discharge of an index admission on these outcomes using machine learning: Primary outcome: Early admission Secondary outcomes: 1. Frequent readmission 2. Composite outcome (Early + Frequent readmissions) 3. Mortality 4. Longstayers

Who May Be Eligible (Plain English)

Who May Qualify: - ≥40 years - Patients are discharged from 2016 -2022 - Discharge Diagnosis: Using the Discharge Diagnosis ICD Codes found in the Primary Diagnosis to determine if a patient has COPD - Validated against Spirometry results (for patient with a spirometry reading): Spirometry reading taken from anytime point before. Patient should have Post FEV1/FVC ratio of \< 0.7 in any one of the spirometry readings. If Post FEV1/FVC is not available, we will check if patients have a Pre FEV1/FVC value, and will also include patients with Pre FEV1/FVC ratio of \< 0.7 in any one of the spirometry readings. Who Should NOT Join This Trial: - Admission diagnosis due to causes other than COPD Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * ≥40 years * Patients are discharged from 2016 -2022 * Discharge Diagnosis: Using the Discharge Diagnosis ICD Codes found in the Primary Diagnosis to determine if a patient has COPD * Validated against Spirometry results (for patient with a spirometry reading): Spirometry reading taken from anytime point before. Patient should have Post FEV1/FVC ratio of \< 0.7 in any one of the spirometry readings. If Post FEV1/FVC is not available, we will check if patients have a Pre FEV1/FVC value, and will also include patients with Pre FEV1/FVC ratio of \< 0.7 in any one of the spirometry readings. Exclusion Criteria: * Admission diagnosis due to causes other than COPD

Treatments Being Tested

OTHER

No intervention

No intervention

Locations (1)

The Chinese University of Hong Kong
Hong Kong, New Territories, Hong Kong